Immunarray Ltd.
Rehovot Tel Aviv, IL· latest recorded location
IMMUNARRAY LTD. is named on 1 US grants and 4 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 1
- Published applications
- 4
- Inventors
- 6
- Granted in 2026 so far
- 0
- Most recent grant
- 29 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
By publication year.
Technology areas
Share of 5 documents
Recent patents
- Sle disease management16 Jul 2020US 2020/0225222 A1
- Diagnosis of autoimmune diseases28 Mar 2019US 2019/0094219 A1
- Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens23 Aug 2018US 2018/0238873 A1
- Methods for determining the risk of a systemic lupus erythematosus (sle) patient to develop neuropsychiatric syndromes16 Aug 2018US 2018/0231565 A1
Most cited
By later US patents